Skip to main content

and
  1. Article

    Open Access

    Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma

    The influence of perioperative blood transfusion (PBT) on postsurgical survival of patients with different stage of hepatocellular carcinoma (HCC) is not well clarified. This study aimed to evaluate the impact...

    Gui-**ng Chen, Chao-Ying Qi, Wen-Jie Hu, **ao-Hui Wang, Yun-Peng Hua in BMC Cancer (2020)

  2. Article

    Open Access

    Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma

    The function of hornerin (HRNR), a member of the S100 protein family, is poorly clarified in the development of human tumors. The role of HRNR in hepatocellular carcinoma (HCC) progression is investigated in t...

    Shun-Jun Fu, Shun-Li Shen, Shao-Qiang Li, Yun-Peng Hua, Wen-Jie Hu in BMC Cancer (2018)

  3. Article

    Open Access

    Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection

    Embryonic Liver Fodrin (ELF) is an adaptor protein of transforming growth factor (TGF-β) signaling cascade. Disruption of ELF results in mislocalization of Smad3 and Smad4, leading to compromised TGF-β signali...

    Fei Ji, Zhi-heng Zhang, Yi Zhang, Shun-Li Shen, Qing-Hua Cao, Long-Juan Zhang in BMC Cancer (2018)

  4. Article

    Open Access

    A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI)

    The occurrence and development of hepatocellular carcinoma (HCC) depends largely on such non-tumor factors as inflammatory condition, immune state, viral infection and liver fibrosis. Various inflammation-base...

    Fei Ji, Yao Liang, Shun-Jun Fu, Zhi-Yong Guo, Man Shu, Shun-Li Shen in BMC Cancer (2016)

  5. Article

    Open Access

    The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma

    Tumor suppression of Transforming Growth Factor (TGF-β) signaling pathway requires an adaptor protein, Embryonic Liver Fodrin (ELF). Disruption of ELF expression resulted in miscolocalization of Smad3 and Smad...

    Fei Ji, Shun-Jun Fu, Shun-Li Shen, Long-Juan Zhang, Qing-Hua Cao in BMC Cancer (2015)

  6. Article

    Open Access

    Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection

    Peripheral blood monocyte count is an easily assessable parameter of systemic inflammatory response. The aim of this study was to determine whether monocyte count was prognostic in hepatocellular carcinoma (HC...

    Shun-Li Shen, Shun-Jun Fu, **ong-Qing Huang, Bin Chen, Ming Kuang in BMC Cancer (2014)

  7. Article

    Open Access

    Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma

    Golgi phosphoprotein 3 (GOLPH3) has been identified as an oncoprotein in various human cancers; however, its role in pancreatic ductal adenocarcinoma (PDAC) is unknown. We examined GOLPH3 expression levels and...

    Luan-**g Zhang, Ke-Bing Wang, Long-shan Liu, Lian-zhou Chen, Bao-Gang Peng in BMC Cancer (2014)

  8. Article

    Open Access

    Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis

    Neutrophil-lymphocyte ratio (NLR) has recently been reported as a predictor of Hepatocellular carcinoma (HCC). However, its prognostic value in HCC still remains controversial. In this study, we aimed to evalu...

    Wei-Kai **ao, Dong Chen, Shao-Qiang Li, Shun-Jun Fu, Bao-Gang Peng in BMC Cancer (2014)

  9. Article

    Open Access

    Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis

    Glypican-3(GPC3) has been implicated in tumor development and progression for several years. However, the prognostic significance of GPC3 expression in patients with hepatocellular carcinoma (HCC) is controver...

    Wei-Kai **ao, Chao-Ying Qi, Dong Chen, Shao-Qiang Li, Shun-Jun Fu in BMC Cancer (2014)